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Abstract
Background: Data entry errors are common in clinical research databases. Omitted data are of particular concern
because they are more common than erroneously inserted data and therefore could potentially affect research
findings. However, few affordable strategies for their prevention are available.
Methods: We have conducted a prospective observational study of the effect of a novel tool called “Summary
Page” on the frequency of correction of omitted data errors in a radiation oncology research database between
July 2008 and March 2009. “Summary Page” was implemented as an optionally accessed screen in the database
that visually integrates key fields in the record. We assessed the frequency of omitted data on the example of the
Date of Relapse field. We considered the data in this field to be omitted for all records that had empty Date of
Relapse field and evidence of relapse elsewhere in the record.
Results: A total of 1,156 records were updated and 200 new records were entered in the database over the study
period. “Summary Page” was accessed for 44% of all updated records and for 69% of newly entered records.
Frequency of correction of the omitted date of cancer relapse was six-fold higher in records for which “Summary
Page” was accessed (p = 0.0003).
Conclusions: “Summary Page” was strongly associated with an increased frequency of correction of omitted data
errors. Further, controlled, studies are needed to confirm this finding and elucidate its mechanism of action.
Background
Data entry errors are common in clinical research studies
[1-3]. Omitted data are particularly significant because
they are more prevalent than erroneously inserted data
and are therefore more likely to lead to errors in analysis
and conclusions [4]. Statistical approaches have been
developed to analyse datasets with missing data, such as
multiple imputation and mixed-effects regression models
[5-8]. However, these methods are applicable only to data
with “missing at random” (MAR) pattern of missingness,
while errors of omission (interpreted as missing data)
usually do not satisfy the MAR requirements. Conse-
quently, omitted data can have a significant effect on
research findings [9].
Reduction in frequency of data errors is important in
order to ensure high quality of data used in clinical
research and the resulting conclusions. However, double-
entry - the gold standard approach for prevention of data
errors - is labor-intensive and costly [10]. Other proposed
approaches such as direct patient contact and more rig-
orous documentation and/or communication policies
may also be labor-intensive and/or not explicitly vali-
dated [11]. It has been shown that the probability of
errors increases in cognitively isolated database fields in
t h ed a t a b a s er e c o r d-f i e l d s ,w h o s ec o n t e n ti si n d e p e n -
dent of the other fields in the record [12]. For example,
the date of the first radiation treatment commonly takes
place soon after the date of diagnosis, but the date of the
last follow-up visit can take place any time after the diag-
nosis and is therefore more error-prone. Based on this
finding, we have developed a novel tool called “Summary
Page” that decreases the incidence of errors in clinical
research databases by enhancing cognitive connectivity
between the fields in the database record. In this study
we evaluated the effect of the “Summary Page” access on
the frequency of correction of omitted data in research
databases.
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Design
We conducted prospective observational analysis of data
entered in a radiation oncology clinical research data-
base to determine whether utilization of the “Summary
Page” was associated with higher frequency of correction
of omitted date of cancer relapse (primary outcome).
Data Sources
We analysed the data from two research databases at the
Department of Radiation Oncology at an academic medi-
cal centre: a) breast cancer treatment database (database
B) and b) sarcoma treatment database (database S). Both
databases contained information about cancer treatment
(including surgery, chemotherapy and radiation) of onco-
logic patients who underwent radiation treatment at the
department. Data in these databases were entered retro-
spectively and the databases were completely separate
from the electronic medical record systems utilized for
clinical care. All data in the databases were entered
manually by trained technicians, usually being copied
from electronic or paper medical records. A typical
record contained the patient’sd e m o g r a p h i c sa n d ,i n f o r -
mation about the diagnosis, co-morbidities, treatment
and outcomes. Database B has 11 data entry forms and
database S has 14 data entry forms for each record.
Analysis of Omitted Data
We analysed the data in database S to determine preva-
lence and co-occurrence of omitted data. In order to dis-
tinguish between the data that was truly missing and
omission errors we identified all records that did not have
any information in the field XRT (X-ray Therapy) Start
Date. These records were subsequently manually reviewed
to obtain XRT Start Date where it could be found. We
then identified records that had missing information in
fields where it would most likely be due to an error of
omission including the patient’s gender, date of birth
(DOB) and cancer site. We compared the prevalence of
missing data in these three fields in the following cate-
gories of records: a) records with no missing XRT Start
Date; b) records with missing XRT Start Date for which
this information could not be found on manual review (i.e.
was not the result of an omission error); and c) records
with missing XRT Start Date for which this information
was subsequently found on manual review (i.e. was the
result of an omission error).
“Summary Page” Tool
The “Summary Page” tool was developed to exploit the
fact that errors are more likely to occur in data fields
that are not cognitively connected to any of the other
fields in the database. It is implemented as a single
screen that has the following major sections (Figure 1):
1. Verbatim listing of selected fields in the record
representing key demographic and clinical information.
2. Schematic representation of the timeline of the
patient’s clinical course.
3. “Possible Error” section that lists likely errors based
on a set of rules that take into account all fields in the
record. Typically these errors, while likely, are not fully
certain, and therefore do not merit an interruptive alert.
An example of a possible error that can be identified in
the breast cancer database is a new surgical procedure
(e.g. modified radical mastectomy after the original lum-
pectomy) without a documented relapse of the cancer
(Figure 2). This is most likely an error where the infor-
mation about the relapse was omitted. However, the
error is not definite since it is also possible that the
patient herself requested a more aggressive procedure in
order to be reassured that the cancer will not recur. Most
rules for identification of possible errors involve data ele-
ments entered on different screens of the database which
may therefore be more difficult for the users to integrate.
In the described implementation of the “Summary Page”
these rules were based on expert opinion but they can
potentially also be derived using formal algorithms,
including supervised and non-supervised learning techni-
ques. A full set of “possible error” rules utilized in the
described implementation of the “Summary Page” is
listed in the Additional File 1.
“Summary Page” aims to reduce the incidence of data
errors through the following mechanisms:
a) Enhancement of cognitive links between the key
fields in the database record through visual integration
on a single screen
b) Identification of possible, though not fully certain,
errors through integrated analysis of the data. For exam-
ple, unexpected treatment activity can be a sign of miss-
ing relapse information
The “Summary Page” was implemented as a single
page in Microsoft Access database that could be option-
ally accessed from anywhere in the record. Users can
access “Summary Page” a n yt i m ed u r i n gd a t ae n t r yp r o -
cess or never access it at all.
“Summary Page” Utilization and Effectiveness
In order to evaluate the effectiveness of the “Summary
Page” tool in reducing the frequency of omitted data we
analyzed the changes to the database records and “Sum-
mary Page” user tracings in database “B” between 07/
04/2008 and 03/04/2009. We assessed the frequency of
omitted data on the example of the Date of Relapse
field. We considered the data in this field to be omitted
for all records that had empty Date of Relapse field and
evidence of relapse elsewhere in the record.
“Summary Page” usage tracings included date, time
and user ID for each “Summary Page” access. We also
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for each edit of the Date of Relapse field. Database users
were not aware that “Summary Page” access was being
monitored.
Statistical Analysis
Summary statistics were constructed by using frequen-
cies and proportions for categorical data. Reported con-
fidence limits (CI) for proportions are exact binomial
CI. Fisher’s Exact Test was used for analyses of bivariate
associations between categorical variables. To identify
the predictors of “Summary Page” access and entry of
an omitted date of relapse we constructed hierarchical
(multilevel) multiple logistic regression models. Both
models adjusted for clustering within individual database
users using repeated effects method. Significance thresh-
olds were adjusted for multiple hypothesis testing using
Simes-Hochberg method [13,14]. All analyses were per-
formed using SAS (Version 9.1; SAS, Cary, NC). All
statistical tests were 2-sided.
IRB
The study protocol was reviewed and approved by the
Partners Human Research Committee.
Results
Data entry omission errors
Database S contained 2,250 records of patients treated
with radiation therapy (XRT) for sarcoma. Of these, 344
records did not contain information about XRT start
Figure 1 “Summary Page” screen in the database. “Summary Page” is implemented as a single screen in Microsoft Access database that has the
following major components. 1. Verbatim listing of selected fields in the patient’s record representing key demographic and clinical information. 2.
Schematic representation of the timeline of the patient’s clinical course. 3. “Possible Error” section that lists likely errors based on integrated analysis
of all fields in the records. Typically these errors while likely, are not fully certain, and therefore do not merit an interruptive alert.
Figure 2 Example of a possible error highlighted by the “Summary Page”. This breast cancer patient was treated with lumpectomy
(excisional biopsy) followed by XRT. Subsequently after no events are recorded for year and a half she has a modified radical mastectomy. This
could indicate a possible error (e.g. omitted date of cancer relapse). However, the error is not definite as sometimes patients request a more
comprehensive surgery on their own without overt clinical indications.
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whether documentation of the XRT start date could be
found in the patient’s records. As a result of manual
verification, XRT start date was identified for 118
(34.3%) records.
Missing data in other fields (Gender, DOB, Cancer
Site) was most common among records with missing
XRT start date that was found on manual review (at
least one of the three fields was missing in 34.7% of the
records) and least common among records (7.6%) where
XRT start date was not missing or the missing XRT
s t a r td a t ec o u l dn o tb es u b s e q u e n t l yi d e n t i f i e do nm a n -
ual verification (p < 0.0001). The difference between the
prevalence of missing data in other fields between
records with correctly vs. erroneously missing XRT start
date was also highly significant (Table 1).
“Summary Page” Utilization
To determine the utilization of the “Summary Page”,w e
analysed all 1356 records (200 new and 1156 updated)
that were entered or updated in database B between 07/
04/2008 and 03/04/2009. Distribution of “Summary
Page” utilization per record is presented in Figure 3.
“Summary Page” was accessed in slightly less than half
(44.2%) of all records. Most commonly it was accessed
only once per record but in 2.4% of the records it was
accessed three or more times. “Summary Page” was
accessed for 69.0% of entries of new records but only
for 40.0% of the updates of the records already in the
database (p = 0.01). Three data entry technicians worked
with the database during this period. Their “Summary
Page” access rate was 84.6%, 47.1% and 11.8%, respec-
tively (p < 0.001).
In multivariable analysis the odds of “Summary Page”
access were 12% higher if the patient’s cancer had T
stage greater than 1 and over 50% higher if this was a
new record rather than an existing one being updated
(Table 2). Patients’ vital status, tumor grade, whether
the cancer had already been recorded as having relapsed
prior to the record update being analyzed, and the year
of diagnosis were not significantly associated with “Sum-
mary Page” access.
“Summary page” Effectiveness
To evaluate the effectiveness of the “Summary Page” we
analysed 1356 records (200 new and 1156 updated) that
were entered or updated between 07/04/2008 and
03/04/2009. Among these, 164 had documented a
remission but had final vital status “Died from Disease”,
indicating that a relapse had taken place. Five of these
164 records (3.05%) did not have any information in the
Date of Relapse field recorded. “Summary Page” was
accessed for 86 of the 164 records. None of the records
where “Summary Page” was accessed had a missing date
of relapse (p = 0.023).
Among the 1,156 records that were updated during
the study period, “Summary Page” was accessed for 462
records. Relapse information was entered after “Sum-
mary Page” access for 16 (3.5%) of the records where
“Summary Page” was utilized and for 4 (0.6%) of the
remaining records (p = 0.0003). In all 16 records where
relapse information was entered after “Summary Page”
access, it was entered within 10 minutes of accessing
the “Summary Page” (typically a single record takes
20-90 minutes to enter de novo and 10-40 minutes to
Table 1 Prevalence and Co-Occurrence of Missing Data
Total Missing Gender, N (%,
95% CI)
Missing DOB, N (%,
95% CI)
Missing Cancer Site N (%,
95% CI)
Record with missing XRT Start not found on
manual review
(no data error)
226 18 (8.0; 4.8-12.3) 15 (6.6; 3.8-10.7) 20 (8.85; 5.5-13.3)
Records with missing XRT Start found on manual
review
(data error: omitted XRT start)
118 18 (15.2; 9.3-23.0) 12 (10.2; 5.4-17.1) 24 (20.3; 13.5-28.7)
P-value
1 <0.0001 0.031 <0.0001
1P-value represents a Fisher exact test between the fractions of records with omitted data among records with omitted vs. not omitted XRT start date.
Figure 3 “Summary Page” Utilization per Record.
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the very first relapse was entered, it was entered within
10 minutes after “Summary Page” access for 7 records
(p = 0.034). In multivariable analysis the odds of entry
of a date of relapse increased by 3.8% if the patient’s
vital status was “Deceased” and by 4.5% if the “Summary
Page” was accessed during the record update (Table 3).
Tumor grade, tumor stage and the year of cancer diag-
nosis were not significantly associated with the probabil-
ity of entry of a date of relapse. There was no significant
difference of probability o fe n t r yo far e l a p s ed a t e
between individual data entry technicians.
Discussion
In this prospective observational study we showed that
utilization of a novel tool - “Summary Page” - is asso-
ciated with lower rates of omitted data in research
databases.
Many types of errors are common in research data-
bases [1,2,12,15]. However, omitted data constitute a
particularly perilous type of error because they are
much more common than erroneously inserted informa-
tion. Non-MAR/non-MCAR type errors of omission in
turn are more likely to affect the conclusions of analysis.
This is well illustrated by the error on which we focused
our evaluation - omitted date of cancer relapse. This
information is not commonly found as a structured field
in electronic medical record systems. Therefore it has to
be manually abstracted from the patient’sr e c o r db y
trained personnel through interpretation and cognitive
integration of multiple types of narrative documents,
including progress notes, operative reports, imaging stu-
dies, pathology reports, etc. Consequently, information
about a relapse date would be easy to miss. On the
other hand, erroneous entry of a non-existing relapse
date is unlikely. Hence, introduction of wrong data and
omission of correct data have different probabilities.
Whereas omitted data in fields containing continuous
variables that are MAR with respect to the information
available in the record might be successfully dealt with
by imputing values based on the other fields in the
record, omitted date of relapse would most likely be
interpreted as a lack of relapse, potentially altering study
conclusions.
Many contemporary electronic data entry systems (e.g.
online stores or banks) allow the user to review the
information they had entered prior to finalizing the
transaction. However, complete data review is not feasi-
ble for clinical research databases whose records typi-
cally have dozens if not hundreds of fields that take up
multiple screens. The “Summary Page” is designed to
mitigate this problem by applying the following princi-
ples: a) focusing on the key fields; b) visually integrating
i n f o r m a t i o ni nt h e s ef i e l d st ofacilitate detection of dis-
crepancies and contradictions; and c) pointing out prob-
ably (though not necessarily definite) errors.
In order to help the user identify possible errors “Sum-
mary Page” aims to facilitate cognitive connections
between different fields in the database by showing them
together on a single screen. For example, “Summary
Page” displays both the date of relapse and the patient’s
treatment dates. If, for example, the patient had che-
motherapy several years after mastectomy but there is no
date of relapse recorded between the surgery and the
chemotherapy, the omission becomes very apparent to
the user. Furthermore, as we showed in the analysis of
prevalence of omitted data, errors of omission frequently
co-occur in the same record. A user who has identified
o n ee r r o ro fo m i s s i o ni nt h er e c o r dm a ya l s ob em o r e
likely to review the rest of the record for other omitted
data. Therefore the increased frequency of correction of
omitted data we observed in the “Summary Page” users
can be due to several mechanisms.
A number of approaches have been used to reduce
errors in research databases. Double-entry of the same
information by multiple personnel followed by verifica-
tion of all discrepancies remains the gold standard but
is expensive. Constraint failure alerts are less costly.
However, not all fields have obvious and persistent con-
straints, limiting applicability of this approach. “Sum-
mary Page” is a method that is at the same time more
flexible than constraint failure and is not labour inten-
sive. Importantly, “Summary Page” was well accepted by
the database users. Despite being completely optional, it
was used in nearly half of all records and in over two
thirds of the new records. “Summary Page” could there-
fore serve as a complement to double entry to improve
its efficiency (by reducing the number of errors to be
Table 2 Predictors of “Summary Page” Access
Predictor Variable Odds of “Summary Page” Access P-value
Deceased 0.99 0.73
Cancer Relapsed 0.94 0.23
Tumor grade “poor” 1.03 0.37
T stage > T1 1.12 0.0018
Diagnosis Year 1.0 0.78
New case 1.51 <0.0001
Table 3 Predictors of Relapse Date Entry
Predictor Variable Odds of Relapse Date Entry P value
Deceased 1.038 0.0026
Tumor grade “poor” 1.006 0.58
T stage > T1 1.008 0.48
Diagnosis Year 1.0 0.79
“Summary Page” accessed 1.045 <0.0001
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the number of errors under circumstances where double
entry is not feasible. Making accessing “Summary Page”
mandatory (e.g. at the end of the editing session for a
particular record) could further increase its impact on
error rates.
“Summary Page” may not be a perfect tool for all set-
tings. It is less likely to be useful for smaller databases
where entering a single record requires only 1-2 screens.
Under these circumstances its benefit of integrating
information from distant parts of the record may be
lower. “Summary Page” is also not a tool that can be used
off-the-shelf. It must be set up individually for each data-
base by qualified personnel who may not be available or
may require additional expense on consultants. Optimal
set-up of the “Summary Page” requires knowledge of the
subject matter and relevant workflow. For example,
unexpected therapeutic activity (e.g. surgery) may indi-
cate a missing cancer relapse information whereas abrupt
discontinuation of radiation therapy may be a sign of
omitted information about radiation toxicity.
Utilization of the “Summary Page” differed signifi-
cantly between the three users, although the low overall
number of the users precludes drawing statistical con-
clusions. The individual with the lowest (11.8%) rate of
utilization of the “Summary Page” was a visiting physi-
cian. Data entry was not one of that individual’s direct
duties and it is possible that this decreased overall moti-
vation. The individual with the highest (84.6%) rate of
utilization was only involved in data entry over a short
period of time immediately after the “Summary Page”
was introduced. It is possible that the novelty of the
technology had contributed to the higher rate of utiliza-
tion. The third individual was the only one who was
involved in the data entry into the study database
throughout the study period and was an experienced
data entry technician in the department. This indivi-
dual’s rate of utilization (47.1%) is representative of the
utilization rates we had observed in day-to-day use of
the “Summary Page” in the department.
Optimal database design remains an important tool for
error prevention. The Date of Relapse field we analyzed
in this study had overloaded the NULL value, which
could mean either that there was no date of relapse (i.e.
the cancer had not relapsed) or that the date of relapse
was not known (e.g. there was information that the can-
cer had relapsed, but the exact date when the relapse was
diagnosed could not be established). Availability of a dis-
tinct Unknown value for the Date of Relapse field would
have likely also decreased the rate of omitted date of
relapse observed in our study.
Our study had several limitations. Its observational
nature and lack of a control group does not allow us to
draw direct inference about the effectiveness of the
“Summary Page”. While the difference between the
number of omitted relapse date values entered with vs.
without the use of the “Summary Page” was large and
highly significant, we do not have information about all
omitted relapse dates in the dataset and therefore can-
not rule out that these were distributed unequally
between the records where “Summary Page” was vs. was
not used, accounting for all or part of this difference.
The effect of the “Summary Page” was evaluated on the
example of a single field in one radiation oncology
research database. It is therefore possible that it may
not be as effective in other settings. “Summary Page”
may require user training to achieve its full potential.
For example, it is unlikely to be helpful if accessed in
the beginning of the data entry session when there is lit-
tle data in the record, but much more helpful in the
end.
Conclusions
In this prospective observational study we have found
that data omission errors in clinical research databases
were common and non-randomly distributed. Utilization
of a novel tool, “Summary Page”, was strongly associated
with an increase in the frequency of correction of
omitted data. Further (e.g. randomised controlled) stu-
dies are needed to confirm this finding and establish the
mechanism of action of the “Summary Page”.
Additional material
Additional file 1: Probable Error Rules. A complete listing of “possible
error” rules utilized in the described implementation of the “Summary Page”.
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